MedPath

Assessing the Potential of C-Reactive Protein Testing to Reduce Antibiotic Dispensation for Respiratory Tract Infections by Community Pharmacists in Nigeria: A Cluster Randomised Controlled Trial

Not Applicable
Conditions
Antibiotic use for respiratory tract infections
Registration Number
PACTR202111611256940
Lead Sponsor
Augustine Onwunduba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

To be included, a community pharmacy must be registered with the Pharmacists Council of Nigeria (PCN) and have at least one pharmacist, who is registered with PCN, on duty always.

Exclusion Criteria

Prospective community pharmacies will be excluded if their managements do not consent to their participating or if their community pharmacists already use a diagnostic technique to inform antibiotic dispensation to patients with RTI symptoms.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This is the rate at which community pharmacists dispense antibiotics to patients with symptoms of RTI.
Secondary Outcome Measures
NameTimeMethod
This is the rate at which community pharmacists incorporate the results of objective medical tests when making decisions regarding antibiotic dispensation to patients with symptoms of RTI.
© Copyright 2025. All Rights Reserved by MedPath